SCHEMBL119336

SCHEMBL119336

COC(=O)c1ccc(S(=O)(=O)N(Cc2ccccc2)c2ncccc2C)cc1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.66
ALDH1A1 P00352 3/20 0.66
TRPM8 Q7Z2W7 7/20 0.61
MAPT P10636 3/20 0.51
PSEN1 P49768 1/20 0.48
PSEN2 P49810 1/20 0.48
APH1B Q8WW43 1/20 0.48
NCSTN Q92542 1/20 0.48
APH1A Q96BI3 1/20 0.48
PSENEN Q9NZ42 1/20 0.48
HPGD P15428 2/20 0.48
HSD17B10 Q99714 1/20 0.48
MMP1 P03956 2/20 0.48
MMP9 P14780 2/20 0.48
MMP13 P45452 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL121457 0.89 TRPM8 (0.76) KDM4EALDH1A1TRPM8HPGDHSD17B10
SCHEMBL118928 0.88 TRPM8 (0.78) KDM4EALDH1A1TRPM8MAPTPSEN1
SCHEMBL119788 0.84 TRPM8 (0.66) KDM4EALDH1A1TRPM8MAPTPSEN1
SCHEMBL121527 0.80 TRPM8 (0.81) KDM4EALDH1A1TRPM8
SCHEMBL119129 0.78 TRPM8 (0.79) KDM4EALDH1A1TRPM8
SCHEMBL119863 0.77 TRPM8 (0.68) KDM4EALDH1A1TRPM8
SCHEMBL1169287 0.76 LMNA (0.73) ALDH1A1MAPTL3MBTL1RAB9A
SCHEMBL118517 0.76 TRPM8 (1.00) KDM4EALDH1A1TRPM8HPGDHSD17B10
SCHEMBL120885 0.75 TRPM8 (0.81) TRPM8
SCHEMBL18422594 0.75 ALDH1A1 (0.64) KDM4EALDH1A1MAPTHPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102427810-A Sulfamoylbenzoic acid derivatives as TRPM8 antagonists RAQUALIA PHARMA INC 2012-04-25 CN disclosed
US-20120094964-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2012-04-19 US disclosed
EP-2424517-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RaQualia Pharma Inc (JP) 2012-03-07 EP disclosed
WO-2010125831-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2010-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094964-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS TRPM8, TRPM5, TRPM6 KDM4E 2411/4885ALDH1A1 1996/4885TRPM8 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.